CS
PHXM

Credit Suisse’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Credit Suisse’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-423
Closed -$5K – 4402
2022
Q2 		$5K Buy
+423
New +$5.23K ﹤0.01% 3765
2022
Q1 		– Sell
-1,690
Closed -$40K – 4467
2021
Q4 		$40K Buy
+1,690
New +$57K ﹤0.01% 4430

Other funds holding PHXM

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Credit Suisse's PHXM Position: Q3 2022 in Review

Credit Suisse sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q3 2022, closing a stake of 423 shares — an estimated $5K sold.

Credit Suisse first reported a position in PHXM in Q4 2021 and held it in 2 quarters. The position peaked at $40K in Q4 2021. 9 funds tracked by Wall St. Rank hold PHXM as of Q3 2022.

  • Credit Suisse reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 423 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q3 2022, an estimated $5K.
  • Credit Suisse first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q4 2021 and held it in 2 quarters.
  • Credit Suisse's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $40K in Q4 2021.
  • 9 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.